United States Pharmaceuticals

Bristol-Myers Squibb Co (BMY)

Track

Track

Bristol-Myers Squibb Co experienced its most recent insider trading activity on April 1, 2026. During this period, Chief Financial Officer David V. Elkins executed multiple planned and proposed sales of company shares. No further transactions have been recorded by corporate leadership within the last three months.
Ticker: BMY Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bristol-Myers Squibb Co. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
107.65
Quantity 56,268 +39.0%
Value US$2,317,810
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
172.15
Quantity 73,125 +13.1%
Value US$4,114,766
1.2
Elkins David V Officer Officer
Transaction date
Proposed sale
Price
345.39
Quantity 74,032
Value US$3,170,906
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
47.33
Quantity 56,000 -25.1%
Value US$2,650,480
1.2
Elkins David V Officer Officer
Transaction date
Proposed sale
Price
47.30
Quantity 56,000
Value US$2,648,800
0.8
Short Bartie Wendy EVP, Corporate Affairs Officer
Transaction date
Sale
Price
44.23
Quantity 378 -6.9%
Value US$16,719
Hickey Benjamin President, RayzeBio Org. Officer
Transaction date
Sale
Price
38.01
Quantity 97 -100.0%
Value US$3,702
2.9
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Officer
Transaction date
Purchase
Price
47.58
Quantity 4,250 +5.4%
Value US$202,215
2.0
BOERNER CHRISTOPHER S. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
55.05
Quantity 2,000 +1.9%
Value US$110,096
2.9
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Officer
Transaction date
Purchase
Price
54.84
Quantity 1,823 +2.9%
Value US$100,000
0.9
Holzer Phil M SVP and Controller Officer
Transaction date
Sale
Price
55.62
Quantity 700 -5.6%
Value US$38,930
0.9
Holzer Phil M Officer Officer
Transaction date
Proposed sale
Price
55.62
Quantity 700
Value US$38,930
2.9
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Officer
Transaction date
Purchase
Price
54.68
Quantity 1,830 +3.0%
Value US$100,055
2.0
BOERNER CHRISTOPHER S. Chief Executive Officer Officer
Transaction date
Purchase
Price
49.78
Quantity 2,000 +2.5%
Value US$99,560
2.0
BOERNER CHRISTOPHER S. Chief Executive Officer Officer
Transaction date
Purchase
Price
48.86
Quantity 3,071 +4.0%
Value US$150,049
3.4
Samuels Theodore R. II Non-Executive Director
Transaction date
Purchase
Price
49.81
Quantity 8,500 +31.5%
Value US$423,385
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
61.25
Quantity 17,986 -39.2%
Value US$1,101,642
3.2
Powell Ann Officer Officer
Transaction date
Proposed sale
Price
61.25
Quantity 17,986
Value US$1,101,653
2.9
Plenge Robert M EVP, Chief Research Officer Officer
Transaction date
Sale
Price
61.14
Quantity 732 -10.0%
Value US$44,754
2.9
Plenge Robert M Officer Officer
Transaction date
Proposed sale
Price
61.14
Quantity 732
Value US$44,756
3.3
VESSEY RUPERT EVP & President, Research Officer
Transaction date
Sale
Price
67.06
Quantity 50,385 -51.3%
Value US$3,378,818
3.3
VESSEY RUPERT Officer Officer
Transaction date
Proposed sale
Price
67.06
Quantity 50,385
Value US$3,378,941
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
74.69
Quantity 11,183 -32.7%
Value US$835,258
3.5
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
74.65
Quantity 240,000 -50.4%
Value US$17,916,000
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
80.45
Quantity 16,250 -32.2%
Value US$1,307,312
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
78.88
Quantity 45,910 -44.6%
Value US$3,621,381
3.5
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Planned sale
Price
69.71
Quantity 25,000 -5.0%
Value US$1,742,750
3.5
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
71.84
Quantity 50,000 -9.1%
Value US$3,592,000
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
70.75
Quantity 25,000 -33.1%
Value US$1,768,750
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
71.29
Quantity 103,951 -46.5%
Value US$7,410,667
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
71.35
Quantity 30,000 -23.0%
Value US$2,140,500
3.5
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
74.04
Quantity 30,000 -5.2%
Value US$2,221,200
2.8
LEUNG SANDRA EVP, General Counsel Officer
Transaction date
Sale
Price
74.89
Quantity 65,000 -17.4%
Value US$4,867,850
3.5
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Planned sale
Price
71.52
Quantity 25,000 -4.1%
Value US$1,788,000
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
69.23
Quantity 43,228 -46.2%
Value US$2,992,674
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
69.27
Quantity 31,331 -40.4%
Value US$2,170,298
1.6
Santiago Karen Murphy SVP & Controller Officer
Transaction date
Sale
Price
69.20
Quantity 6,577 -28.3%
Value US$455,096
2.0
BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
69.20
Quantity 29,532 -41.3%
Value US$2,043,526
3.5
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
67.00
Quantity 30,000 -6.2%
Value US$2,010,000
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.99
Quantity 13,100 -29.1%
Value US$812,069
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.99
Quantity 6,198 -12.1%
Value US$384,183
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
56.92
Quantity 17,353 -21.5%
Value US$987,733
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
57.47
Quantity 15,418 -16.0%
Value US$886,072
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
57.17
Quantity 18,363 -16.0%
Value US$1,049,813
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
68.08
Quantity 140,653 -75.0%
Value US$9,575,656
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
68.01
Quantity 17,740 -32.6%
Value US$1,206,497
2.4
Schmukler Louis S EVP,Pres.,Glob.Prod. & Supply Officer
Transaction date
Sale
Price
65.25
Quantity 15,000 -31.9%
Value US$978,750
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
64.29
Quantity 30,546 -40.4%
Value US$1,963,802
3.0
Dubow Adam SVP,ChiefCompliance&EthicsOff. Officer
Transaction date
Sale
Price
64.21
Quantity 3,119 -16.1%
Value US$200,271
3.5
Caforio Giovanni Chairman and CEO Executive Director
Transaction date
Planned sale
Price
62.20
Quantity 25,000 -4.5%
Value US$1,555,000
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
63.50
Quantity 3 -0.0%
Value US$190
3.0
Dubow Adam SVP,ChiefCompliance&EthicsOff. Officer
Transaction date
Sale
Price
63.39
Quantity 900 -5.6%
Value US$57,051
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
62.75
Quantity 20,000 -13.6%
Value US$1,255,000
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.34
Quantity 13,421 -26.1%
Value US$823,244
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.31
Quantity 47,012 -47.8%
Value US$2,882,306
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.25
Quantity 10,579 -18.7%
Value US$647,964
3.5
Caforio Giovanni Chairman and CEO Executive Director
Transaction date
Sale
Price
62.70
Quantity 39,840 -8.2%
Value US$2,497,968
2.3
Eid Joseph SVP,Head Glob. Medical Affairs Officer
Transaction date
Sale
Price
64.00
Quantity 5,327 -67.8%
Value US$340,928
2.8
LEUNG SANDRA EVP, General Counsel Officer
Transaction date
Sale
Price
63.24
Quantity 141,420 -24.6%
Value US$8,943,401
3.6
Paliwal Dinesh C Non-Executive Director
Transaction date
Purchase
Price
54.50
Quantity 9,174 +70.9%
Value US$499,983
3.0
Dubow Adam SVP,ChiefCompliance&EthicsOff. Officer
Transaction date
Sale
Price
61.01
Quantity 3,200 -16.6%
Value US$195,232
2.4
Schmukler Louis S EVP,Pres.,Glob.Prod. & Supply Officer
Transaction date
Sale
Price
62.68
Quantity 25,000 -48.3%
Value US$1,567,000
2.3
Elicker John E EVP, Investor Relations Officer
Transaction date
Sale
Price
61.01
Quantity 15,805 -21.2%
Value US$964,263
3.3
VESSEY RUPERT Pres., Research & Early Dev. Officer
Transaction date
Sale
Price
60.59
Quantity 84,308 -63.6%
Value US$5,108,222
Dubow Adam Chief Compliance & Ethics Offi Officer
Transaction date
Sale
Price
58.81
Quantity 1,740 -9.9%
Value US$102,329
3.0
BONNEY MICHAEL W Non-Executive Director
Transaction date
Purchase
Price
58.90
Quantity 88 +1.2%
Value US$5,183
Elicker John E SVP, Public Affairs & IR Officer
Transaction date
Sale
Price
56.66
Quantity 15,000 -16.8%
Value US$849,900
Schmukler Louis S Pres., Global Mfg. & Supply Officer
Transaction date
Sale
Price
56.56
Quantity 25,000 -43.9%
Value US$1,414,000
BERTOLINI ROBERT J Non-Executive Director
Transaction date
Purchase
Price
44.72
Quantity 11,000 +2770.8%
Value US$491,920
1.6
Santiago Karen Murphy Controller
Transaction date
Sale
Price
47.56
Quantity 3,065 -50.0%
Value US$145,771
3.4
Samuels Theodore R. II
Transaction date
Purchase
Price
47.29
Quantity 5,000 +22.7%
Value US$236,440
Paliwal Dinesh C Non-Executive Director
Transaction date
Purchase
Price
52.40
Quantity 4,770 +146.5%
Value US$249,948
Samuels Theodore R. II
Transaction date
Purchase
Price
62.30
Quantity 4,000 +22.2%
Value US$249,187
Lynch Thomas J. Jr. EVP & Chief Scientific Officer
Transaction date
Sale
Price
63.24
Quantity 5,300 -36.4%
Value US$335,172
LEUNG SANDRA EVP, General Counsel
Transaction date
Sale
Price
63.37
Quantity 156,582 -26.8%
Value US$9,922,601
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-02 2026-04-01 PlS Planned sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
56,268 +39.0%
107.65
US$2,317,810 		56,268 +39.0% 107.65 US$2,317,810
2026-04-02 2026-04-01 PlS Planned sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
73,125 +13.1%
172.15
US$4,114,766 		73,125 +13.1% 172.15 US$4,114,766
2026-04-01 2026-04-01 PrS Proposed sale
1.2
Elkins David V

Officer

Officer
74,032
345.39
US$3,170,906 		74,032 345.39 US$3,170,906
2025-09-03 2025-09-02 PlS Planned sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
56,000 -25.1%
47.33
US$2,650,480 		56,000 -25.1% 47.33 US$2,650,480
2025-09-02 2025-09-02 PrS Proposed sale
1.2
Elkins David V

Officer

Officer
56,000
47.30
US$2,648,800 		56,000 47.30 US$2,648,800
2025-08-05 2025-08-02 S Sale
0.8
Short Bartie Wendy

EVP, Corporate Affairs

Officer
378 -6.9%
44.23
US$16,719 		378 -6.9% 44.23 US$16,719
2025-05-13 2025-05-09 S Sale
Hickey Benjamin

President, RayzeBio Org.

Officer
97 -100.0%
38.01
US$3,702 		97 -100.0% 38.01 US$3,702
2025-04-29 2025-04-25 B Purchase
2.9
Hirawat Samit

EVP,Chief Med.Offr.,Drug Dev.

Officer
4,250 +5.4%
47.58
US$202,215 		4,250 +5.4% 47.58 US$202,215
2025-02-21 2025-02-20 B Purchase
2.0
BOERNER CHRISTOPHER S.

Chief Executive Officer

Executive Director
2,000 +1.9%
55.05
US$110,096 		2,000 +1.9% 55.05 US$110,096
2025-02-19 2025-02-14 B Purchase
2.9
Hirawat Samit

EVP,Chief Med.Offr.,Drug Dev.

Officer
1,823 +2.9%
54.84
US$100,000 		1,823 +2.9% 54.84 US$100,000
2024-11-05 2024-11-04 S Sale
0.9
Holzer Phil M

SVP and Controller

Officer
700 -5.6%
55.62
US$38,930 		700 -5.6% 55.62 US$38,930
2024-11-04 2024-11-04 PrS Proposed sale
0.9
Holzer Phil M

Officer

Officer
700
55.62
US$38,930 		700 55.62 US$38,930
2024-11-05 2024-11-01 B Purchase
2.9
Hirawat Samit

EVP,Chief Med.Offr.,Drug Dev.

Officer
1,830 +3.0%
54.68
US$100,055 		1,830 +3.0% 54.68 US$100,055
2023-12-07 2023-12-05 B Purchase
2.0
BOERNER CHRISTOPHER S.

Chief Executive Officer

Officer
2,000 +2.5%
49.78
US$99,560 		2,000 +2.5% 49.78 US$99,560
2023-11-30 2023-11-28 B Purchase
2.0
BOERNER CHRISTOPHER S.

Chief Executive Officer

Officer
3,071 +4.0%
48.86
US$150,049 		3,071 +4.0% 48.86 US$150,049
2023-11-21 2023-11-20 B Purchase
3.4
Samuels Theodore R. II
Non-Executive Director
8,500 +31.5%
49.81
US$423,385 		8,500 +31.5% 49.81 US$423,385
2023-08-28 2023-08-24 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
17,986 -39.2%
61.25
US$1,101,642 		17,986 -39.2% 61.25 US$1,101,642
2023-08-24 2023-08-24 PrS Proposed sale
3.2
Powell Ann

Officer

Officer
17,986
61.25
US$1,101,653 		17,986 61.25 US$1,101,653
2023-08-07 2023-08-03 S Sale
2.9
Plenge Robert M

EVP, Chief Research Officer

Officer
732 -10.0%
61.14
US$44,754 		732 -10.0% 61.14 US$44,754
2023-08-03 2023-08-03 PrS Proposed sale
2.9
Plenge Robert M

Officer

Officer
732
61.14
US$44,756 		732 61.14 US$44,756
2023-05-04 2023-05-03 S Sale
3.3
VESSEY RUPERT

EVP & President, Research

Officer
50,385 -51.3%
67.06
US$3,378,818 		50,385 -51.3% 67.06 US$3,378,818
2023-05-03 2023-05-03 PrS Proposed sale
3.3
VESSEY RUPERT

Officer

Officer
50,385
67.06
US$3,378,941 		50,385 67.06 US$3,378,941
2023-02-08 2023-02-06 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
11,183 -32.7%
74.69
US$835,258 		11,183 -32.7% 74.69 US$835,258
2023-02-08 2023-02-06 S Sale
3.5
Caforio Giovanni

Board Chair and CEO

Executive Director
240,000 -50.4%
74.65
US$17,916,000 		240,000 -50.4% 74.65 US$17,916,000
2022-11-14 2022-11-09 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
16,250 -32.2%
80.45
US$1,307,312 		16,250 -32.2% 80.45 US$1,307,312
2022-11-09 2022-11-07 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
45,910 -44.6%
78.88
US$3,621,381 		45,910 -44.6% 78.88 US$3,621,381
2022-09-22 2022-09-20 PlS Planned sale
3.5
Caforio Giovanni

Board Chair and CEO

Executive Director
25,000 -5.0%
69.71
US$1,742,750 		25,000 -5.0% 69.71 US$1,742,750
2022-09-16 2022-09-15 S Sale
3.5
Caforio Giovanni

Board Chair and CEO

Executive Director
50,000 -9.1%
71.84
US$3,592,000 		50,000 -9.1% 71.84 US$3,592,000
2022-09-15 2022-09-14 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
25,000 -33.1%
70.75
US$1,768,750 		25,000 -33.1% 70.75 US$1,768,750
2022-09-15 2022-09-13 S Sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
103,951 -46.5%
71.29
US$7,410,667 		103,951 -46.5% 71.29 US$7,410,667
2022-09-15 2022-09-13 S Sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
30,000 -23.0%
71.35
US$2,140,500 		30,000 -23.0% 71.35 US$2,140,500
2022-06-14 2022-06-13 S Sale
3.5
Caforio Giovanni

Board Chair and CEO

Executive Director
30,000 -5.2%
74.04
US$2,221,200 		30,000 -5.2% 74.04 US$2,221,200
2022-06-07 2022-06-06 S Sale
2.8
LEUNG SANDRA

EVP, General Counsel

Officer
65,000 -17.4%
74.89
US$4,867,850 		65,000 -17.4% 74.89 US$4,867,850
2022-03-23 2022-03-21 PlS Planned sale
3.5
Caforio Giovanni

Board Chair and CEO

Executive Director
25,000 -4.1%
71.52
US$1,788,000 		25,000 -4.1% 71.52 US$1,788,000
2022-03-18 2022-03-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
43,228 -46.2%
69.23
US$2,992,674 		43,228 -46.2% 69.23 US$2,992,674
2022-03-18 2022-03-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
31,331 -40.4%
69.27
US$2,170,298 		31,331 -40.4% 69.27 US$2,170,298
2022-03-16 2022-03-14 S Sale
1.6
Santiago Karen Murphy

SVP & Controller

Officer
6,577 -28.3%
69.20
US$455,096 		6,577 -28.3% 69.20 US$455,096
2022-03-16 2022-03-14 S Sale
2.0
BOERNER CHRISTOPHER S.

EVP, Chief Commercial Officer

Officer
29,532 -41.3%
69.20
US$2,043,526 		29,532 -41.3% 69.20 US$2,043,526
2022-02-28 2022-02-24 S Sale
3.5
Caforio Giovanni

Board Chair and CEO

Executive Director
30,000 -6.2%
67.00
US$2,010,000 		30,000 -6.2% 67.00 US$2,010,000
2021-12-17 2021-12-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
13,100 -29.1%
61.99
US$812,069 		13,100 -29.1% 61.99 US$812,069
2021-12-17 2021-12-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
6,198 -12.1%
61.99
US$384,183 		6,198 -12.1% 61.99 US$384,183
2021-11-24 2021-11-24 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
17,353 -21.5%
56.92
US$987,733 		17,353 -21.5% 56.92 US$987,733
2021-11-24 2021-11-23 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
15,418 -16.0%
57.47
US$886,072 		15,418 -16.0% 57.47 US$886,072
2021-11-24 2021-11-22 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
18,363 -16.0%
57.17
US$1,049,813 		18,363 -16.0% 57.17 US$1,049,813
2021-08-03 2021-07-30 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
140,653 -75.0%
68.08
US$9,575,656 		140,653 -75.0% 68.08 US$9,575,656
2021-08-03 2021-07-30 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
17,740 -32.6%
68.01
US$1,206,497 		17,740 -32.6% 68.01 US$1,206,497
2021-05-11 2021-05-10 S Sale
2.4
Schmukler Louis S

EVP,Pres.,Glob.Prod. & Supply

Officer
15,000 -31.9%
65.25
US$978,750 		15,000 -31.9% 65.25 US$978,750
2021-05-07 2021-05-05 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
30,546 -40.4%
64.29
US$1,963,802 		30,546 -40.4% 64.29 US$1,963,802
2021-05-07 2021-05-05 S Sale
3.0
Dubow Adam

SVP,ChiefCompliance&EthicsOff.

Officer
3,119 -16.1%
64.21
US$200,271 		3,119 -16.1% 64.21 US$200,271
2021-03-24 2021-03-22 PlS Planned sale
3.5
Caforio Giovanni

Chairman and CEO

Executive Director
25,000 -4.5%
62.20
US$1,555,000 		25,000 -4.5% 62.20 US$1,555,000
2020-11-30 2020-11-25 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
3 -0.0%
63.50
US$190 		3 -0.0% 63.50 US$190
2020-11-25 2020-11-24 S Sale
3.0
Dubow Adam

SVP,ChiefCompliance&EthicsOff.

Officer
900 -5.6%
63.39
US$57,051 		900 -5.6% 63.39 US$57,051
2020-11-25 2020-11-24 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
20,000 -13.6%
62.75
US$1,255,000 		20,000 -13.6% 62.75 US$1,255,000
2020-11-25 2020-11-23 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
13,421 -26.1%
61.34
US$823,244 		13,421 -26.1% 61.34 US$823,244
2020-11-23 2020-11-19 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
47,012 -47.8%
61.31
US$2,882,306 		47,012 -47.8% 61.31 US$2,882,306
2020-11-23 2020-11-19 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
10,579 -18.7%
61.25
US$647,964 		10,579 -18.7% 61.25 US$647,964
2020-09-02 2020-08-31 S Sale
3.5
Caforio Giovanni

Chairman and CEO

Executive Director
39,840 -8.2%
62.70
US$2,497,968 		39,840 -8.2% 62.70 US$2,497,968
2020-08-19 2020-08-17 S Sale
2.3
Eid Joseph

SVP,Head Glob. Medical Affairs

Officer
5,327 -67.8%
64.00
US$340,928 		5,327 -67.8% 64.00 US$340,928
2020-08-17 2020-08-13 S Sale
2.8
LEUNG SANDRA

EVP, General Counsel

Officer
141,420 -24.6%
63.24
US$8,943,401 		141,420 -24.6% 63.24 US$8,943,401
2020-06-16 2020-06-15 B Purchase
3.6
Paliwal Dinesh C
Non-Executive Director
9,174 +70.9%
54.50
US$499,983 		9,174 +70.9% 54.50 US$499,983
2020-05-26 2020-05-22 S Sale
3.0
Dubow Adam

SVP,ChiefCompliance&EthicsOff.

Officer
3,200 -16.6%
61.01
US$195,232 		3,200 -16.6% 61.01 US$195,232
2020-05-21 2020-05-19 S Sale
2.4
Schmukler Louis S

EVP,Pres.,Glob.Prod. & Supply

Officer
25,000 -48.3%
62.68
US$1,567,000 		25,000 -48.3% 62.68 US$1,567,000
2020-03-06 2020-03-04 S Sale
2.3
Elicker John E

EVP, Investor Relations

Officer
15,805 -21.2%
61.01
US$964,263 		15,805 -21.2% 61.01 US$964,263
2020-03-04 2020-03-02 S Sale
3.3
VESSEY RUPERT

Pres., Research & Early Dev.

Officer
84,308 -63.6%
60.59
US$5,108,222 		84,308 -63.6% 60.59 US$5,108,222
2019-12-09 2019-12-05 S Sale Dubow Adam

Chief Compliance & Ethics Offi

Officer
1,740 -9.9%
58.81
US$102,329 		1,740 -9.9% 58.81 US$102,329
2020-06-09 2019-12-04 B Purchase
3.0
BONNEY MICHAEL W
Non-Executive Director
88 +1.2%
58.90
US$5,183 		88 +1.2% 58.90 US$5,183
2019-11-06 2019-11-05 S Sale Elicker John E

SVP, Public Affairs & IR

Officer
15,000 -16.8%
56.66
US$849,900 		15,000 -16.8% 56.66 US$849,900
2019-11-06 2019-11-05 S Sale Schmukler Louis S

Pres., Global Mfg. & Supply

Officer
25,000 -43.9%
56.56
US$1,414,000 		25,000 -43.9% 56.56 US$1,414,000
2019-08-01 2019-07-31 B Purchase BERTOLINI ROBERT J Non-Executive Director
11,000 +2770.8%
44.72
US$491,920 		11,000 +2770.8% 44.72 US$491,920
2019-05-20 2019-05-16 S Sale
1.6
Santiago Karen Murphy

Controller
3,065 -50.0%
47.56
US$145,771 		3,065 -50.0% 47.56 US$145,771
2019-05-20 2019-05-16 B Purchase
3.4
Samuels Theodore R. II
5,000 +22.7%
47.29
US$236,440 		5,000 +22.7% 47.29 US$236,440
2018-05-02 2018-04-30 B Purchase Paliwal Dinesh C Non-Executive Director
4,770 +146.5%
52.40
US$249,948 		4,770 +146.5% 52.40 US$249,948
2017-12-18 2017-12-15 B Purchase Samuels Theodore R. II
4,000 +22.2%
62.30
US$249,187 		4,000 +22.2% 62.30 US$249,187
2017-12-13 2017-12-12 S Sale Lynch Thomas J. Jr.

EVP & Chief Scientific Officer
5,300 -36.4%
63.24
US$335,172 		5,300 -36.4% 63.24 US$335,172
2017-12-05 2017-12-04 S Sale LEUNG SANDRA

EVP, General Counsel
156,582 -26.8%
63.37
US$9,922,601 		156,582 -26.8% 63.37 US$9,922,601
Explore more

More insider trading research around Bristol-Myers Squibb Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America
Insider trades in S&P 500